REFERENCES
1. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve
implantation for aortic stenosis in patients who cannot undergo surgery.N Engl J Med 2010; 363(17):1597-607.
2. Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical
aortic-valve replacement in high-risk patients. N Engl J Med2011; 364(23):2187-98.
3. Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter Aortic-Valve
Replacement with a Self-Expanding Valve in Low-Risk Patients. N
Engl J Med 2019; 380(18):1706-1715.
4. Mack MJ, Leon MB, Thourani VH, et al. Transcatheter Aortic-Valve
Replacement with a Balloon-Expandable Valve in Low-Risk Patients.N Engl J Med 2019; 380(18):1695-1705.
5. Carroll JD, Mack MJ, Vemulapalli S, et al. STS-ACC TVT Registry of
Transcatheter Aortic Valve Replacement. Ann Thorac Surg 2021;
111(2):701-722.
6. Boskovski MT, Nguyen TC, Mccabe JM, et al. Outcomes of Transcatheter
Aortic Valve Replacement in Patients With Severe Aortic Stenosis.JAMA Surgery 2020; 155(1):69.
7. Azraai M, Gao L, Ajani AE. Cost-Effectiveness of Transcatheter Aortic
Valve Intervention (TAVI) Compared to Surgical Aortic Valve Replacement
(SAVR) in Low- to Intermediate-Surgical-Risk Patients. Cardiovasc
Revasc Med 2020; 21(9):1164-1168.
8. Baron SJ, Wang K, House JA, et al. Cost-Effectiveness of
Transcatheter Versus Surgical Aortic Valve Replacement in Patients With
Severe Aortic Stenosis at Intermediate Risk. Circulation 2019;
139(7):877-888.
9. Fairbairn TA, Meads DM, Hulme C, et al. The cost-effectiveness of
transcatheter aortic valve implantation versus surgical aortic valve
replacement in patients with severe aortic stenosis at high operative
risk. Heart 2013; 99(13):914-20.
10. Reynolds MR, Lei Y, Wang K, et al. Cost-Effectiveness of
Transcatheter Aortic Valve Replacement With a Self-Expanding Prosthesis
Versus Surgical Aortic Valve Replacement. J Am Coll Cardiol 2016;
67(1):29-38.
11. Zhou JY, Liew D, Duffy SJ, et al. Cost-Effectiveness of
Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk
Patients With Severe Aortic Stenosis. Heart Lung Circ 2021;
30(4):547-554.
12. Tam DY, Hughes A, Fremes SE, et al. A cost-utility analysis of
transcatheter versus surgical aortic valve replacement for the treatment
of aortic stenosis in the population with intermediate surgical risk.J Thorac Cardiovasc Surg 2018; 155(5):1978-1988.e1.
13. Manolis AS. Transcatheter aortic valve implantation economics: a
grisly reality. Annals of Cardiothoracic Surgery 2017;
6(5):516-523.
14. Butala NM, Chung M, Secemsky EA, et al. Conscious Sedation Versus
General Anesthesia for Transcatheter Aortic Valve Replacement: Variation
in Practice and Outcomes. JACC Cardiovasc Interv 2020;
13(11):1277-1287.
15. Fröhlich GM, Lansky AJ, Webb J, et al. Local versus general
anesthesia for transcatheter aortic valve implantation
(TAVR)–systematic review and meta-analysis. BMC medicine 2014;
12:41-41.
16. Mayr NP, Wiesner G, Husser O, et al. Critical adverse events during
transfemoral TAVR in conscious sedation. Is an anesthesiologic support
mandatory? Cardiovascular Revascularization Medicine 2018;
19(6):41-46.
17. Ben-Dor I, Looser PM, Maluenda G, et al. Transcatheter aortic valve
replacement under monitored anesthesia care versus general anesthesia
with intubation. Cardiovasc Revasc Med 2012; 13(4):207-10.
18. Bergmann L, Kahlert P, Eggebrecht H, et al. Transfemoral aortic
valve implantation under sedation and monitored anaesthetic care–a
feasibility study. Anaesthesia 2011; 66(11):977-82.
19. Brecker SJ, Bleiziffer S, Bosmans J, et al. Impact of Anesthesia
Type on Outcomes of Transcatheter Aortic Valve Implantation (from the
Multicenter ADVANCE Study). Am J Cardiol 2016; 117(8):1332-8.
20. Kimmel J, Potosky R, Williams MR, et al. Conversion from Monitored
Anesthesia Care to General Anesthesia for Transcatheter Aortic Valve
Replacement. J Cardiothorac Vasc Anesth 2018; 32(2):1032-1040.
21. Kislitsina ON, Smith D, Sherwani SS, et al. Comparison of Monitored
Anesthesia Care and General Anesthesia for Transcatheter Aortic Valve
Replacement. Innovations (Phila) 2019; 14(5):436-444.
22. Abbett SK, Urman RD, Resor C, et al. The Impact of Anesthesia Type
on Outcomes in Patients Undergoing Transcatheter Aortic Valve
Replacement. Journal of Cardiothoracic and Vascular Anesthesia2020.
23. Thiele H, Kurz T, Feistritzer H-J, et al. General versus Local
Anesthesia with Conscious Sedation in Transcatheter Aortic Valve
Implantation: The Randomized SOLVE-TAVI Trial. Circulation 2020.
24. Babaliaros V, Devireddy C, Lerakis S, et al. Comparison of
Transfemoral Transcatheter Aortic Valve Replacement Performed in the
Catheterization Laboratory (Minimalist Approach) Versus Hybrid Operating
Room (Standard Approach). JACC: Cardiovascular Interventions2014; 7(8):898-904.
25. Toppen W, Johansen D, Sareh S, et al. Improved costs and outcomes
with conscious sedation vs general anesthesia in TAVR patients: Time to
wake up? PloS one 2017; 12(4):e0173777-e0173777.
26. Mosleh W, Mather JF, Amer MR, et al. Propensity Matched Analysis
Comparing Conscious Sedation Versus General Anesthesia in Transcatheter
Aortic Valve Implantation. Am J Cardiol 2019; 124(1):70-77.
27. Coylewright M, Forrest JK, McCabe JM, et al. TAVR in Low-Risk
Patients: FDA Approval, the New NCD, and Shared Decision-Making. J
Am Coll Cardiol 2020; 75(10):1208-1211.
28. Feldman D, Romashko M, Koethe B, et al. COMORBIDITY BURDEN AND
ADVERSE OUTCOMES AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT.Journal of the American College of Cardiology 2020; 75(11):1423.
29. Hall PS, O’Donnell CI, Mathew V, et al. Outcomes of Veterans
Undergoing TAVR Within Veterans Affairs Medical Centers: Insights From
the Veterans Affairs Clinical Assessment, Reporting, and Tracking
Program. JACC Cardiovasc Interv 2019; 12(21):2186-2194.
30. Mack MJ, Leon MB, Smith CR, et al. 5-year outcomes of transcatheter
aortic valve replacement or surgical aortic valve replacement for high
surgical risk patients with aortic stenosis (PARTNER 1): a randomised
controlled trial. Lancet 2015; 385(9986):2477-84.
31. Anantha-Narayanan M, Kandasamy VV, Reddy YN, et al. Low-Risk
Transcatheter Versus Surgical Aortic Valve Replacement - An Updated
Meta-Analysis of Randomized Controlled Trials. Cardiovasc Revasc
Med 2020; 21(4):441-452.
32. Ando T, Ashraf S, Villablanca P, et al. Meta-Analysis of
Effectiveness and Safety of Transcatheter Aortic Valve Implantation
Versus Surgical Aortic Valve Replacement in Low-to-Intermediate Surgical
Risk Cohort. Am J Cardiol 2019; 124(4):580-585.
33. Okoh AK, Haik N, Haik B, et al. Periprocedural complications after
transcatheter aortic valve replacement and their impact on resource
utilization. Cardiovascular Revascularization Medicine 2020.
34. Hirji S, Mcgurk S, Kiehm S, et al. Utility of 90-Day Mortality vs
30-Day Mortality as a Quality Metric for Transcatheter and Surgical
Aortic Valve Replacement Outcomes. JAMA Cardiology 2020;
5(2):156.
35. Sammour Y, Kerrigan J, Banerjee K, et al. Comparing outcomes of
general anesthesia and monitored anesthesia care during transcatheter
aortic valve replacement: The Cleveland Clinic Foundation experience.Catheter Cardiovasc Interv 2021.
36. Ahmad M, Patel JN, Vipparthy SC, et al. Conscious Sedation Versus
General Anesthesia in Transcatheter Aortic Valve Replacement: A Cost and
Outcome Analysis. Cureus 2019.
37. Lau W, Shannon F, Hanzel GS, et al. OUTCOME-BASED COST ANALYSIS OF
TRANSFEMORAL TRANSCATHETER AORTIC VALVE REPLACEMENT USING FASCIA ILIACA
COMPARTMENT BLOCK AND MINIMALIST CONSCIOUS SEDATION APPROACH VERSUS
GENERAL ANESTHESIA. Journal of the American College of Cardiology2017; 69(11):1330.
38. Patel S, Lindenberg M, Rovers MM, et al. Understanding the Costs of
Surgery: A Bottom-Up Cost Analysis of Both a Hybrid Operating Room and
Conventional Operating Room. Int J Health Policy Manag 2020.
39. Potter BJ, Ann Thompson C. Cost of operating room time for
endovascular transcatheter aortic valve replacement. J Med Econ2019; 22(10):1022-1024.
40. Rong LQ, Gaudino M, Tam D, et al. Impact of operator characteristics
on outcomes in transcatheter aortic valve replacement. The Annals
of Thoracic Surgery 2020.
41. Carroll JD, Vemulapalli S, Dai D, et al. Procedural Experience for
Transcatheter Aortic Valve Replacement and Relation to Outcomes.Journal of the American College of Cardiology 2017; 70(1):29-41.
42. Khera S, Kolte D, Gupta T, et al. Association Between Hospital
Volume and 30-Day Readmissions Following Transcatheter Aortic Valve
Replacement. JAMA Cardiology 2017; 2(7):732.
43. Nugent GN, Hendricks A, Nugent L, et al. Value for taxpayers’
dollars: what VA care would cost at medicare prices. Med Care Res
Rev 2004; 61(4):495-508.
44. Hynes DM, Stroupe KT, Fischer MJ, et al. Comparing VA and private
sector healthcare costs for end-stage renal disease. Med Care2012; 50(2):161-70.
45. Barnett PG, Hong JS, Carey E, et al. Comparison of Accessibility,
Cost, and Quality of Elective Coronary Revascularization Between
Veterans Affairs and Community Care Hospitals. JAMA Cardiol 2018;
3(2):133-141.